Laurus Labs Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
LAURUSLABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Laurus Labs Limited has submitted its financial results for the quarter and nine months ended December 31, 2025 to the stock exchange. This is a routine regulatory filing under SEBI's listing obligations, disclosing the company's Q3 FY26 performance. The actual detailed numbers (revenue, profit, margins) are contained in the results document itself and are not reproduced in this notice. Investors should refer to the accompanying financial results PDF for segment-wise performance, consolidated and standalone figures, and management commentary.
This is a procedural submission notice rather than a material event, so it is unlikely to move the stock on its own. The market reaction will depend entirely on the actual numbers in the results — particularly revenue trajectory, PAT growth, and margin trends in Laurus Labs' CDMO, APIs, and formulations segments.